NIB Holdings Ltd · ASX:NHF
NIB — BBY Healthcare and Life Science Conference 2009
20 slides from NIB's conference presentation, Nov 24, 2009
Slide 1: nib holdings Healthcare and Life Science Conference
| nib holdings HEALTHCARE AND LIFE SCIENCE CONFERENCE 24 NOVEMBER
Slide 2: For personal use only
For personal use only Healthcare spending About nib and our challenges Progress thus far Looking L ki ahead h d
Slide 3: Healthcare
=) nib holdings HEALTHCARE
Slide 4: Worldwide healthcare costs are rapidly increasing
Worldwide healthcare costs are rapidly increasing For personal use only Across OECD, healthcare spending has for the past 50 years increased at GDP + 2% % 1960 2008 USA 5.1 16.0 Australia 4.7 9.7 United Kingdom 3.9 8.5 USA now spends $US 2.5 trillion pa on healthcare (cf food $1 trillion) 4
Slide 5: We're all spending more because of:
We’re all spending more because of: For personal use only Increasing wealth and incomes Ageing and longevity Cost C t off technology t h l and d hi higher h utilisation tili ti The rise and rise of chronic disease Moral hazard 5
Slide 6: Australian context
Australian context For personal use only Healthcare spending about $100 billion pa - $4500 per capita Government dominated tax funded social insurance system (Medicare, PBS and public hospitals) About 9.8 million people have private hospital insurance (45% population) and 11.3 million general
Slide 7: PHI participation continues to grow
PHI participation continues to grow For personal use only In FY09 the industryy grew g by y 3.3% or 315,269 ppersons covered In Q1 FY10 the industry grew by 0.8% or 94,171 persons covered As at 30 September 2009, 11.3 million Australians had private health insurance 7
Slide 8: Australia with its increasing dependency ratio must embrace more private funding
Australia with its increasing dependency ratio For personal use only mustt embrace b more private i t funding f di Source: Australian Government (2007) 8
Slide 9: About nib
=) nib holdings ABOUT nib
Slide 10: Snapshot
Snapshot For personal use only Only ASX listed private heath insurer – market capitalisation circa $660 million FY09 premium income of $830 million Fifth largest insurer covering approximately 770,000 lives in all states (7.2% market share) Net assets of $361 million (as at 30 June 2009) wit
Slide 11: Our challenges
Our challenges g For personal use only Growing earnings and optimising capital to achieve and sustain ROE of at least a eas 15% 5% Competing with a free alternative Product differentiation in a commoditised market and price competitiveness nib’s relatively small scale and playing a key role
Slide 12: Tackling the challenges
Tackling the challenges For personal use only Organic growth through: • Targeting “new “ to category” <40 segment • Extending brand reach nationally Establish ongoing price advantage and profitability through “better better risk” strategy and improved productivity/efficiency Demutualisation an
Slide 13: nib and targeting <40 segment
nib and targeting < 40 segment For personal use only Brand reputation and positioning Fit for f purpose products: d t • Deductibles and restrictive benefits • Emphasis on ancillary cover Price competitiveness Distribution 13
Slide 14: Progress
=) nib holdings PROGRESS
Slide 15: nib v system growth
nib v system growth For personal use only CAGR of 6.6% (system: 2.9%) since FY05 nib’s net policyholder growth for Q1 FY10 of 6,923 policies (same period 09 = 6,5 FY09 6,549)9) o or 1.8% 8% (syste (system: 0.8%) 0 8%) In Q1 FY10 nib accounted for 17% of total industry growth nib’s growth in
Slide 16: The efficacy of our business strategy
The efficacy of our business strategy For personal use only ((%)) FY05 FY06 FY07 FY08 FY09 Net policyholder growth (nib) 4.2 3.9 8.8 11.1 5.2 Net policyholder growth rate (industry) 0.8 2.1 4.2 4.2 3.2 % of new sales new to category (nib) 68 7 68.7 70 8 70.8 74 4 74.4 78 2 78.2 67 4 67.4 % of new sa
Slide 17: The pay off
The pay off For personal use only Underlying earnings increased 21.8% in FY09 to $40.2 million Underlying ROE* of 1111.3% 3% in FY08 and 1111.2% 2% in FY09 TSR since listing of 73.5% (as at close of trade 17 November 2009) * Normalised investment income for FY09 calculated on the basis of 5.5%
Slide 18: Looking ahead
=) nib holdings LOOKING
Slide 19: Looking ahead
Looking ahead For personal use only Net underwriting result forecast to increase as much as 25% in FY10 (FY10 net underwriting result forecast of $45 - 50 million and g margin net underwriting g of 5-5.5%)) PHI system growth of GDP +1-2% with nib consistently doing better (FY10 guidance of 4-6%
Slide 20: nib holdings Healthcare and Life Science Conference
| nib holdings HEALTHCARE AND LIFE SCIENCE CONFERENCE 24 NOVEMBER
nib holdings — BBY Healthcare and Life Science Conference 2009 on 6ix